Kevin R. Jain MD


Board Certifications

2013
Hematology (Internal Medicine), Board Certified
2012
Internal Medicine, Board Certified
Medical Oncology, Board Eligible

Patient Care Locations

kevin_jainfaculty-clinicsfalsetruetrue6truefalsefalse

Clinical Trials

ConditionsStudy Title
Colorectal Cancer and ColonA Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer (CALGB 80702)
LungS1400: Phase II/III Biomarker-Driven Master Protocol for Second Line Therapy of Squamous Cell Lung Cancer
ColonS0820: A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients with Stage 0-III Colon Cancer, Phase III - Preventing Adenomas of the Colon with Eflornithine and Sulindac (PACES)
Breast - FemaleS1222: FULVESTRANT ALONE VERSUS FULVESTRANT AND EVEROLIMUS VERSUS FULVESTRANT, EVEROLIMUS AND ANASTROZOLE: A PHASE III RANDOMIZED PLACEBO-CONTROLLED TRIAL IN POSTMENOPAUSAL PATIENTS WITH HORMONE-RECEPTOR-POSITIVE STAGE IV BREAST CANCER
Leukemia, otherA Randomized Phase III Study of Bendamustine Plus Rituximab Versus Ibrutinib Plus Rituximab Versus Ibrutinib Alone in Untreated Older Patients (=65 Years of Age) with Chronic Lymphocytic Leukemia (CLL)

More Clinical Trials...

Edit Profile